Cargando…
Efficacy and safety of adalimumab in hidradenitis suppurativa: A systematic review and meta-analysis of randomized controlled trials
BACKGROUND: Adalimumab is used as a first-line biologic agent in the management of moderate-to-severe hidradenitis suppurativa (HS). The objective of the present study was to evaluate the efficacy and safety of adalimumab in patients with moderate-to-severe HS. METHODS: We performed a systematic rev...
Autores principales: | Lu, Jing-Wun, Huang, Yu-Wen, Chen, Tai-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183777/ https://www.ncbi.nlm.nih.gov/pubmed/34087885 http://dx.doi.org/10.1097/MD.0000000000026190 |
Ejemplares similares
-
Perineal burn injury with hidradenitis suppurativa: A case report
por: Wang, Linyue, et al.
Publicado: (2022) -
Hidradenitis suppurativa associated with systemic lupus erythematosus: A case report
por: Ben David, Chen, et al.
Publicado: (2018) -
Apremilast for the treatment of hidradenitis suppurativa associated with psoriatic arthritis in multimorbid patients: Case report and review of literature
por: Garcovich, Simone, et al.
Publicado: (2020) -
Successful surgical treatment for squamous cell carcinoma arising from hidradenitis suppurativa: A case report and literature review
por: Huang, Cheng, et al.
Publicado: (2017) -
Citation analysis of the 100 top-cited articles on the topic of hidradenitis suppurativa since 2013 using Sankey diagrams: Bibliometric analysis
por: Yang, Ting-Ya, et al.
Publicado: (2022)